Comparing Progyny (NASDAQ:PGNY) & Auna (NYSE:AUNA)

Auna (NYSE:AUNA) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Auna and Progyny, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	1	2	2	1	2.50
Progyny	0	3	9	1	2.85

Auna presently has a consensus target price of $7.30, suggesting a potential upside of 28.30%. Progyny has a consensus target price of $29.36, suggesting a potential upside of 17.45%. Given Auna’s higher possible upside, research analysts clearly believe Auna is more favorable than Progyny.

Profitability

This table compares Auna and Progyny’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Auna	4.40%	13.52%	3.27%
Progyny	4.46%	10.71%	7.27%

Institutional and Insider Ownership

94.9% of Progyny shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Risk & Volatility

Auna has a beta of 2.26, suggesting that its stock price is 126% more volatile than the S&P 500. Comparatively, Progyny has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.

Valuation & Earnings

This table compares Auna and Progyny”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$1.17 billion	0.36	$29.39 million	$0.71	8.01
Progyny	$1.17 billion	1.85	$54.34 million	$0.63	39.68

Progyny has lower revenue, but higher earnings than Auna. Auna is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

Summary

Progyny beats Auna on 9 of the 14 factors compared between the two stocks.

About Auna

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

About Progyny

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.